PRCs achieve an average 95% patient retention rate in Moderna vaccine trial
Take a look at how our Patient Recruitment Centres prioritise the participants’ experience to support excellent patient retention rates.
- Published: 09 August 2023
Take a look at how our Patient Recruitment Centres prioritise the participants’ experience to support excellent patient retention rates.
Explore the timeline of our research to help develop the Oxford-AstraZeneca COVID-19 vaccine and its impact to reduce transmission and save lives.
Learn how the NIHR enabled NHS Trusts in North West London to collaborate to deliver vital vaccine studies.
Learn how the UK’s Urgent Public Health prioritisation process enabled rapid delivery of the Novavax COVID-19 vaccine trial, recruiting over 15,000 participants in two months.
The pneumococcal vaccine schedule changed after a NIHR-funded trial demonstrated that fewer injections can deliver immunity in the UK.
Find out how NIHR support gave global pharmaceutical company, GlaxoSmithKline (GSK), the confidence to bring care home research to the UK.